Home › Seattle Genetics Enters Into New Antibody-Drug Conjugate Collaboration With Bayer
 

Keywords :   


Seattle Genetics Enters Into New Antibody-Drug Conjugate Collaboration With Bayer

2013-06-25 09:00:00| drugdiscoveryonline News Articles

Seattle Genetics, Inc. recently announced that it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare (Bayer)

Tags: with collaboration seattle enters

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11
23.11 85
23.11DANCEWITHDRAGON2 811
23.11 N5000VSE
23.11EZY POWER EDIT6
23.11RR4
23.1126.5 HG
23.11VISSLA
More »